Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Aug 2007 17:57

2 ergo Group plc16 August 2007 Immediate release: 16 August 2007 2ergo Group plc ('2ergo' or 'the Company') Holdings in the Company 2ergo announces that it was today informed by AXA S.A. and its group companies,that it has an interest in 1,450,770 ordinary shares representing 5.07% of theissued ordinary share capital of the Company. -ends- For further information, please contact: 2ergo Group 01706 221 777 Jill Collighan, Finance Director Tavistock Communications 020 7920 3150 Lulu Bridges/Andrew Dunn This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jul 200510:35 amRNSHolding(s) in Company
27th Jun 20057:00 amRNSAcquisition
25th May 20052:30 pmRNSDirector Shareholding
11th May 20057:00 amRNSInterim Results
3rd May 200512:06 pmRNSNotice of Results
3rd May 20057:00 amRNSShare Buy Back
7th Apr 20052:45 pmRNSAGM Statement
14th Mar 20059:15 amRNSm-commerce initiative
7th Mar 20057:00 amRNSTrading Statement
7th Mar 20057:00 amRNSNotice of AGM
28th Feb 200512:27 pmRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.